P-Shot Side Effects: What Are the Real Risks?
Men considering the P-Shot — also known as the Priapus Shot or P shot treatment — deserve clear, evidence-based information about potential risks. PRP therapy for men’s performance issues attracts growing interest across the UK. Yet discussions of P shot side effects remain far less prominent than the promotional content that dominates search results. This article corrects that imbalance.
The P-Shot is not a cosmetic procedure. It is an intracavernosal injection of autologous platelet-rich plasma (PRP) — a concentrated fraction of the patient’s own blood — administered directly into the corpus cavernosum of the penis. As a regenerative treatment for male health in the UK, it sits within the broader category of advanced PRP solutions for erectile dysfunction. Like every clinical intervention, it carries a defined risk profile that every informed patient must understand before proceeding.
This article examines the known P shot risks, the mechanisms behind each adverse event, the current state of clinical evidence, and the key questions to ask before any consultation. It does not advocate for or against the treatment. It presents what peer-reviewed literature and regulatory guidance currently support.
Patients searching for non-surgical treatment for erectile dysfunction in London will find a growing number of clinics offering PRP-based regenerative therapy for ED. Understanding the risk-benefit balance is the essential first step.
What Is the P-Shot and How Does It Work?
The P-Shot is a form of penile injection growth therapy. Blood is drawn from the patient’s arm, processed in a centrifuge to isolate platelet-rich plasma, and then injected into targeted penile tissue under local anaesthetic.
Platelets release growth factors — including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor-beta (TGF-β). These growth factors theoretically stimulate neovascularisation, tissue remodelling, and smooth muscle regeneration within the corpus cavernosum.
The mechanism is biologically plausible. Endothelial dysfunction drives the majority of organic erectile dysfunction (ED) presentations. Growth-factor delivery to cavernosal tissue may improve local blood flow. However, the clinical translation of this mechanism into reproducible patient outcomes remains under active investigation.
Patients comparing P shot before and after experiences should note that self-reported outcomes vary considerably across published case series. No single P-shot before and after benchmark represents the expected response for an average patient.
P Shot Side Effects: A Comprehensive Clinical Review
The available evidence identifies a range of P shot side effects. These fall into two broad categories: immediate procedural effects and post-procedure complications.
Immediate Post-Procedural Side Effects
Bruising (Ecchymosis)
Bruising is the most frequently reported P shot side effect. The penis receives injection at multiple sites during a standard P shot treatment session. Minor ecchymosis typically resolves within 7–14 days. This reflects superficial capillary disruption rather than deep tissue damage.
Swelling (Oedema)
Localised oedema following a penis shot procedure is common and expected. Tissue disruption from the needle and the volume of injected PRP solution both contribute to swelling. This usually resolves within 48–72 hours. Persistent oedema beyond five days warrants clinical review.
Discomfort and Pain at the Injection Site
Penile injection procedures carry inherent discomfort risks even with topical anaesthetic cream. Most practitioners apply a lidocaine-based topical numbing agent 20–30 minutes before the injection. Post-procedure soreness typically subsides within 24–48 hours. Severe or worsening pain is not expected and requires urgent assessment.
Temporary Skin Discolouration
Superficial skin discolouration at the injection site may accompany bruising. This is generally transient and resolves as the bruising fades. Persistent pigmentation changes are not well documented in the current literature.
Less Common P Shot Complications
Haematoma Formation
A haematoma represents a collection of blood outside the vascular system within penile tissue. This is a clinically significant P shot complication that requires prompt evaluation. Risk increases in patients on anticoagulant or antiplatelet medications. Clinicians conducting P shot treatment should screen for medication use pre-procedure.
Infection
Infection risk exists with any invasive injection procedure. The use of autologous PRP — derived from the patient’s own blood — reduces the risk of immune-mediated rejection or foreign-body infection. However, injection-site skin flora, poor sterile technique, or compromised patient immunity can still introduce bacteria into penile tissue.
Signs of infection include increasing pain, warmth, erythema, and discharge at the injection site beyond 48 hours. Any suspected infection following a P injection requires urgent medical review. NHS guidance on infection prevention applies to all invasive aesthetic and regenerative procedures.
Nodule Formation
A small number of case reports describe subcutaneous nodule formation following penile PRP injection. These nodules may reflect localised fibrotic tissue response to the injected material. The incidence is not well characterised in current literature. Palpable nodules that persist beyond four weeks should be assessed by a clinician with experience in PRP complications.
Priapism
Priapism — a prolonged, painful erection unrelated to sexual stimulation — is a rare but serious potential complication. Although rare in the P-Shot literature, any intracavernosal injection carries a theoretical risk of priapism. This is a urological emergency. Patients must receive clear verbal and written instructions on this risk before undergoing any penile injection growth therapy.
Penile Fibrosis
Repeated intracavernosal injections — particularly in the context of other concurrent treatments — carry a risk of penile fibrosis. Fibrosis refers to scar tissue formation within cavernosal tissue. This is better documented with pharmacological intracavernosal injections (prostaglandin E1) than with PRP specifically. However, practitioners should assess cumulative injection history before proceeding with a P shot UK consultation.
PRP Side Effects: What the Evidence Actually Shows
PRP side effects across all clinical applications share a common profile. A 2021 systematic review in the Journal of Clinical Medicine evaluated PRP injection outcomes across musculoskeletal, dermatological, and urological uses. The authors consistently identified bruising, swelling, and transient pain as the most common adverse events — typically self-limiting and resolving within two weeks.
In the specific context of erectile dysfunction treatment London, a 2019 study published in Sexual Medicine (Matz et al.) examined intracavernosal PRP injections in men with ED. The study reported no serious adverse events. Minor side effects — predominantly bruising and temporary discomfort — occurred in a subset of participants and resolved without intervention.
The overall PRP safety profile appears favourable when administered by a qualified clinician using appropriate sterile technique. This assessment is consistent with the European Association of Urology (EAU) position that regenerative treatments using autologous biologics carry low systemic risk when procedural standards are met.
Importantly, this positive safety signal does not indicate that P shot risks are absent. It indicates that the risk profile is predominantly local, procedural, and time-limited — not systemic or irreversible — in the majority of reported cases.
Who Faces the Highest P Shot Risk?
Not all patients present equal procedural risk. Clinicians offering men’s intimate health treatment in London should assess each patient’s individual risk profile before proceeding.
Patients on Anticoagulant Medication
Patients taking warfarin, rivaroxaban, apixaban, or antiplatelet agents such as aspirin and clopidogrel face elevated bleeding and haematoma risk. Temporary cessation of anticoagulation therapy may be advisable before a penile injection procedure. This decision requires coordination with the prescribing clinician. Patients must not self-discontinue anticoagulation without medical supervision.
Patients with Active Genital Infection
Any active skin or urogenital infection represents a contraindication to the P-Shot. Introducing a needle through infected or inflamed tissue dramatically increases the risk of deep-tissue infection. Standard clinical screening should include visual inspection and relevant microbiological history.
Patients with Blood Disorders
Platelet dysfunction disorders — including thrombocytopaenia and conditions requiring platelet inhibitors — affect PRP quality and procedural safety. Blood-borne infections such as HIV and hepatitis B or C do not represent absolute contraindications under current guidance, but require careful protocol adherence.
Patients with Prior Penile Surgery or Peyronie’s Disease
Altered penile anatomy from prior surgery, implants, or Peyronie’s disease changes the risk profile for intracavernosal injections. P shot complications in these patients may differ from those in men with no prior penile pathology. A detailed anatomical assessment is essential before treatment.
What the Evidence Does Not Yet Support
Beyond the known P shot side effects, clinicians and patients must recognise where the evidence base has clear limitations. Several claims associated with the P-Shot — including significant penile enlargement and permanent reversal of organic ED — lack robust RCT-level support.
Penile Enlargement Claims
No large-scale randomised controlled trial has validated the P-Shot as a reliable penile enlargement intervention. Anecdotal reports and small uncontrolled case series describe modest increases in penile girth or length in some patients. These outcomes are not reproducible across all patients and should not be presented as predictable results of male enlargement injections.
Patients researching male enlargement injections cost UK should be cautious of providers who guarantee specific size outcomes. No ethical clinician can guarantee dimensional changes from a biological injection that relies on individual tissue response.
Long-Term ED Reversal
Natural ED treatment using PRP therapy has theoretical merit. However, current evidence does not support the claim that the P-Shot permanently reverses organic ED. Results from published studies are variable, and many trial designs lack placebo controls. A 2022 double-blind RCT published in European Urology Focus found no statistically significant difference between PRP injection and saline placebo in IIEF score improvements at 12 weeks.
Men considering an advanced PRP solution for erectile dysfunction should discuss realistic expectations — including the possibility of non-response — with their clinician before treatment.
Regulatory and Safety Standards in the UK
The P-Shot is not licensed or regulated as a medical device or pharmaceutical product by the Medicines and Healthcare products Regulatory Agency (MHRA). It sits within the category of autologous cell therapies, which occupy a distinct regulatory space.
NICE does not currently issue specific guidance on intracavernosal PRP for erectile dysfunction. This absence of NICE endorsement does not indicate prohibition, but it does indicate that the treatment falls outside the standard NHS pathway. P shot treatment in the UK is delivered exclusively within private medical settings.
The Care Quality Commission (CQC) regulates private medical facilities in England. Patients seeking a Priapus shot London should verify that their chosen clinic holds current CQC registration and that the administering clinician holds appropriate specialist qualifications.
Priapus shot price in the UK varies by clinic, location, and practitioner experience. Pricing alone should not guide treatment decisions. Clinician qualifications, procedural standards, and clinical environment are the primary determinants of safety.
How to Minimise P Shot Risks
Procedural risk is not fixed. Appropriate clinical protocols substantially reduce the frequency and severity of P shot side effects.
- Select a clinician who has formal training in PRP therapy and intracavernosal injection techniques.
- Before treatment, attend a comprehensive medical consultation that includes a full review of your medications.
- The procedure should always be performed in a clinical environment using sterile, single‑use equipment.
- Afterward, refrain from strenuous physical activity and sexual intercourse for at least 48–72 hours.
- Make sure you receive written post‑procedure care instructions before leaving the clinic.
- If you notice signs of infection or priapism, seek immediate medical attention without delay.
P-Shot vs. Established ED Treatments: A Contextual Comparison
Patients weighing PRP-based regenerative therapy for ED against established interventions benefit from a direct comparison of safety profiles.
PDE5 Inhibitors (Sildenafil, Tadalafil)
First-line oral pharmacotherapy for ED carries a well-characterised safety profile validated across decades of clinical use. Side effects include headache, flushing, dyspepsia, and — in rare cases — visual disturbance. PDE5 inhibitors are contraindicated in patients taking nitrate medications. NICE and the British Society for Sexual Medicine (BSSM) recommend these as first-line therapy for vasculogenic ED.
Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT)
Li-ESWT is a non-invasive regenerative treatment that targets the same neovascularisation mechanism as the P-Shot. The safety data for Li-ESWT is more extensive than for PRP injection, with EAU guidelines noting its applicability in carefully selected patients.
Testosterone Replacement Therapy (TRT)
TRT addresses hypogonadism-associated ED. Its risks — polycythaemia, lipid changes, testicular volume reduction, and cardiovascular implications — are systemic rather than local. TRT is appropriate only where biochemical hypogonadism is confirmed.
The P-Shot’s risk profile differs from all of the above. Its risks are primarily local and procedural. Its clinical evidence base is more limited. It occupies a supplementary or adjunctive position rather than a first-line role in current clinical frameworks.
Frequently Asked Questions: P Shot Side Effects
Are P shot side effects permanent?
The most commonly reported P shot side effects — bruising, swelling, and injection-site discomfort — are temporary. They typically resolve within one to two weeks. Serious complications such as haematoma, infection, or nodule formation are uncommon and, when they occur, generally respond to appropriate medical management. No large-scale study has documented permanent adverse events attributable solely to PRP injection into the corpus cavernosum.
Is the P-Shot painful?
Topical local anaesthetic cream is applied before the procedure to minimise discomfort. Most patients report that the injection itself causes minimal pain. Post-procedure soreness is common for 24–48 hours. Severe pain during or after the procedure is not expected and should be reported to the treating clinician immediately.
Can the P-Shot cause erectile dysfunction?
There are no well-documented cases in the published literature of the P-Shot directly causing or worsening erectile dysfunction in previously potent men. However, as with any intracavernosal injection, fibrosis risk exists with repeated procedures. Patients should discuss this with their clinician.
How many P-Shot sessions are needed?
Protocols vary by clinician and patient response. Some protocols recommend a single initial session with reassessment at 4–6 weeks. Others recommend two or three injections at monthly intervals. The evidence base does not currently support a universally agreed optimal protocol.
Who should not have the P-Shot?
Patients with active penile infection, platelet dysfunction disorders, certain blood-borne conditions, or significant bleeding disorders should not undergo this procedure without specialist assessment. Patients on anticoagulant medication require individual clinical evaluation before treatment.
Does the Priapus shot price reflect clinical quality?
Priapus shot London pricing varies widely and does not reliably reflect clinical quality or safety standards. Patients should evaluate clinician qualifications, clinical environment, and consultation quality rather than price alone.
What is the difference between the P-Shot and penile filler?
This distinction is clinically critical. The P-Shot involves autologous PRP injection to stimulate tissue regeneration and improve erectile function. Cosmetic penile filler involves the injection of synthetic hyaluronic acid to increase penile girth. These are distinct procedures with different risk profiles, mechanisms, and clinical applications. They must not be conflated.
Conclusion: Informed Consent Is the Foundation of Safe Treatment
The P-Shot occupies an evolving space within regenerative medicine. Its safety profile — based on available evidence — is broadly favourable for procedural adverse events. Serious P shot complications are uncommon when treatment is performed by a qualified clinician using appropriate technique.
However, the absence of serious adverse events in small case series is not the same as confirmed long-term safety in large populations. The current evidence base for P shot side effects is largely derived from small, uncontrolled studies. Patients deserve transparent communication about what is known, what is uncertain, and what cannot yet be predicted.
Men considering PRP therapy for men’s performance issues — particularly non-surgical treatment for erectile dysfunction in London — should undergo a thorough medical consultation, receive full written information on risks and expected outcomes, and ensure their treating clinician holds verifiable specialist qualifications.
At pshots clinic uk, P shot treatment is led by Dr Syed Nadeem Abbas (MBBS, MRCS RCS Edinburgh, MRCGP, MSc Aesthetic Plastic Surgery with Distinction), whose clinical background spans Cambridge, Oxford, and the Royal London Hospital.
Every credible regenerative treatment begins with an honest conversation about risk. The P-Shot is no exception. The question worth considering is not simply whether this treatment might work — but whether you have received the full clinical picture needed to decide if it is right for you.
read more: When Will I See Results from P Shot in London? A Realistic Timeline
P Shot London: How to Choose a Safe Clinic and What to Expect at Your Consultation